Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2707]

AACR 2013: Novel drug combination showed antitumour activity in patients with incurable BRCA-deficient cancers

AACR 2013: Novel drug combination showed antitumour activity in patients with incurable BRCA-deficient cancers

AACR 2013: New type of experimental drug active in platinum-resistant ovarian cancers

AACR 2013: New type of experimental drug active in platinum-resistant ovarian cancers

AACR 2013: Biomarker analysis identified women most likely to benefit from T-DM1

AACR 2013: Biomarker analysis identified women most likely to benefit from T-DM1

IMW 2013: Cereblon is can predict response to immunomodulatory drug therapy and survival outcomes in multiple myeloma

IMW 2013: Cereblon is can predict response to immunomodulatory drug therapy and survival outcomes in multiple...

IMW 2013: Assessing renal impairment in myeloma

IMW 2013: Assessing renal impairment in myeloma

IMW 2013: Daratumumab granted fast track designation by the FDA

IMW 2013: Daratumumab granted fast track designation by the FDA

Functional characteristics of antitumour T cells change with increasing time after therapeutic transfer

Functional characteristics of antitumour T cells change with increasing time after therapeutic transfer

EAU 13: Epigenetic changes play a key role in development of chemo resistance in BCa

EAU 13: Epigenetic changes play a key role in development of chemo resistance in BCa

A patient charter for CINV management

A patient charter for CINV management

Chemo given into the abdomen could boost ovarian cancer survival

Chemo given into the abdomen could boost ovarian cancer survival

More from ecancer